search icon

Menu

Abacavir

CAT NO : SZ-AXXXX | CAS NO : 136470-78-5

Abacavir (ABC) is a nucleoside reverse transcriptase inhibitor (NRTI). It is used to treat HIV and AIDS. It is often used in combination with other HIV medications. Abacavir is available as a single medication and in fixed-dose combinations with other drugs like lamivudine and zidovudine.

The chemical name of Abacavir is (1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-ylmethanol. Abacavir works by interfering with the action of an enzyme called reverse transcriptase, which the HIV virus needs to copy itself. By blocking this enzyme, abacavir helps to reduce the amount of HIV in the body and strengthens the immune system. This, in turn, helps to delay the progression of HIV infection and improve the overall health and quality of life for people living with HIV/AIDS.

Pharmaceutical Reference Standards

Abacavir EP Impurity A
Chemical Structure
CAT No SRC-N014974
CAS No NA
Mol.F. C15H18N6O
Mol.Wt. 298.4 g/mol
INV STATUS IN STOCK
N-Nitroso Deschloprom
Chemical Structure
CAT No SZ-A013003
CAS No NA
Mol.F. C12H16N6O
Mol.Wt. 260.30 g/mol
INV STATUS OUT OF STOCK
N-Nitroso Tadalafil
Chemical Structure
CAT No SZ-A013003
CAS No NA
Mol.F. C12H16N6O
Mol.Wt. 260.30 g/mol
INV STATUS OUT OF STOCK
N-Nitroso Sildenafil
Chemical Structure
CAT No SZ-A013003
CAS No NA
Mol.F. C12H16N6O
Mol.Wt. 260.30 g/mol
INV STATUS OUT OF STOCK
N-Nitroso Deschloprom
Chemical Structure
CAT No SZ-A013003
CAS No NA
Mol.F. C12H16N6O
Mol.Wt. 260.30 g/mol
INV STATUS OUT OF STOCK
N-Nitroso Tadalafil
Chemical Structure
CAT No SZ-A013003
CAS No NA
Mol.F. C12H16N6O
Mol.Wt. 260.30 g/mol
INV STATUS OUT OF STOCK
N-Nitroso Sildenafil
Chemical Structure
CAT No SZ-A013003
CAS No NA
Mol.F. C12H16N6O
Mol.Wt. 260.30 g/mol
INV STATUS OUT OF STOCK
N-Nitroso Tadalafil
Chemical Structure
CAT No SZ-A013003
CAS No NA
Mol.F. C12H16N6O
Mol.Wt. 260.30 g/mol
INV STATUS OUT OF STOCK
1 2 3 4 ... 10

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.